59 related articles for article (PubMed ID: 34973097)
1. Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer [Letter].
Winarni S; Martiningsih W; Retnaningtyas E
Cancer Manag Res; 2023; 15():1349-1350. PubMed ID: 38058538
[No Abstract] [Full Text] [Related]
2. Sexual experiences and information needs among patients with prostate cancer: a qualitative study.
Haining Z; Xiaoli Z; Jiping Z; Beibei Z; Ping M; Yunfei G
Sex Med; 2024 Apr; 12(2):qfae019. PubMed ID: 38596664
[TBL] [Abstract][Full Text] [Related]
3. Perspectives and Concerns on Late Effects Regarding Sexuality among Adolescents and Young Adults Treated for Testicular Germ Cell Tumor: The PRICELESS-Study-A Qualitative Study.
Kuiper ST; Zweers D; Suelmann BBM; Meijer RP; Vervoort SCJM
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398106
[TBL] [Abstract][Full Text] [Related]
4. Care needs of Japanese men for sexual dysfunction associated with prostate cancer treatment.
Hayashi S; Sato K; Oishi F; Fukuda H; Hayama Y; Ando S
Support Care Cancer; 2023 Jun; 31(7):378. PubMed ID: 37273083
[TBL] [Abstract][Full Text] [Related]
5. Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer.
Hollenbeck BK; Dunn RL; Wei JT; Sandler HM; Sanda MG
Curr Urol Rep; 2004 Jun; 5(3):212-9. PubMed ID: 15161570
[TBL] [Abstract][Full Text] [Related]
6. Sexual dysfunction associated with prostate cancer treatment in Japanese men: a qualitative research.
Hayashi S; Oishi F; Sato K; Fukuda H; Ando S
Support Care Cancer; 2022 Apr; 30(4):3201-3213. PubMed ID: 34973097
[TBL] [Abstract][Full Text] [Related]
7. Defining sexual outcomes after treatment for localized prostate carcinoma.
Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
[TBL] [Abstract][Full Text] [Related]
8. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.
Wilt TJ; MacDonald R; Rutks I; Shamliyan TA; Taylor BC; Kane RL
Ann Intern Med; 2008 Mar; 148(6):435-48. PubMed ID: 18252677
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy between Expectations and Experiences after Prostate Cancer Treatment: A Dutch Multicenter Study.
Grondhuis Palacios LA; van Zanten P; den Ouden MEM; Krouwel EM; Beck JJH; Reisman Y; Putter H; Pelger RCM; Elzevier HW; den Oudsten BL
Urology; 2019 Dec; 134():135-142. PubMed ID: 31494212
[TBL] [Abstract][Full Text] [Related]
10. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
[TBL] [Abstract][Full Text] [Related]
11. Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: Analysis from the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation database.
Okihara K; Yorozu A; Saito S; Tanaka N; Koga H; Higashide S; Kikuchi T; Nakano M
Int J Urol; 2017 Jul; 24(7):518-524. PubMed ID: 28455847
[TBL] [Abstract][Full Text] [Related]
12. The experiences and needs of couples affected by prostate cancer aged 65 and under: a qualitative study.
Collaço N; Wagland R; Alexis O; Gavin A; Glaser A; Watson EK
J Cancer Surviv; 2021 Apr; 15(2):358-366. PubMed ID: 32968952
[TBL] [Abstract][Full Text] [Related]
13. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
Hoffman KE; Penson DF; Zhao Z; Huang LC; Conwill R; Laviana AA; Joyce DD; Luckenbaugh AN; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Koyama T; Barocas DA
JAMA; 2020 Jan; 323(2):149-163. PubMed ID: 31935027
[TBL] [Abstract][Full Text] [Related]
14. Subcapsular orchiectomy versus total orchiectomy and LHRH analogue in the treatment of hormone-sensitive metastatic prostate cancer: a different perspective in evaluation of the psychosocial effects.
Selvi I; Basar H
Support Care Cancer; 2020 Sep; 28(9):4313-4326. PubMed ID: 31912363
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
